Atrial and Ventricular Myopathy: A Novel Risk Predictor for Stroke and Cardiovascular Events

Atrial and Ventricular Myopathy: A Novel Risk Predictor for Stroke and Cardiovascular Events

“The question is, what came first: the chicken or the egg?” said Nassir F. Marrouche, MD, noting that every AF patient has some kind of fibrosis or myopathy in their heart, in the atrium at least. He says research findings have sparked a debate regarding the relationship.

Read More
Tammy Griffin-Kumpey
Keeping to the beat in rate control

Keeping to the beat in rate control

Speaking to Boston AF Symposium News, Kevin Heist (Massachusetts General Hospital, Boston, MA, USA) laid out the indications of different rate-controlling agents and his hopes as to what future research could address.

Read More
Tammy Griffin-Kumpey
New Insights into the Mechanistic Links between Inflammation, Oxidative Stress and AF, and Prevention of AF: A Basic Scientist’s Perspective

New Insights into the Mechanistic Links between Inflammation, Oxidative Stress and AF, and Prevention of AF: A Basic Scientist’s Perspective

“We often conclude that, as atrial fibrillation (AF) occurs with increasing frequency with advancing age in both men and women, the occurrence of AF is inevitable,” said David Van Wagoner, PhD, ahead of his presentation.

Read More
Tammy Griffin-Kumpey
Stroke prevention and the left atrial appendage

Stroke prevention and the left atrial appendage

The impact of left atrial appendage (LAA) closure on atrial fibrillation and the function of the left atrium formed the basis of an insightful talk from Dhanunjaya Lakkireddy (University of Kansas Medical Center, Kansas) during a session on protecting the brain in AF.

Read More
Tammy Griffin-Kumpey
AFACART: Noninvasive mapping in right direction

AFACART: Noninvasive mapping in right direction

The utility, procedural benefits and comparative efficacy of a 252-electrode noninvasive mapping system for AF will be placed under the spotlight this afternoon, with Sebastien Knecht (Brugmann University Hospital, Brussels, Belgium) outlining key results from the ongoing AFACART trial.

Read More
Tammy Griffin-Kumpey
Impact of atrial remodeling on AF outcomes

Impact of atrial remodeling on AF outcomes

Marking the very first presentation of the 2015 AF Symposium, Prashanthan Sanders from the Royal Adelaide Hospital, Australia, kick-started proceedings on Thursday morning with an exploration of the mechanisms of atrial remodeling and their impact of AF outcomes.

Read More
Tammy Griffin-Kumpey
Looking beyond PVI for persistent AF termination

Looking beyond PVI for persistent AF termination

Professor Haissaguerre and colleagues applied noninvasive signal processing to identify driver domains in 103 patients, demonstrating that driver sites can be mapped accurately, leading to shorter RF times than conventional ablation techniques. He discussed the work in an interview with AF Symposium News.

Read More
Tammy Griffin-Kumpey
Epicardial and endocardial approaches to LAA closure

Epicardial and endocardial approaches to LAA closure

Epicardial techniques present advantages over some aspects of endocardial devices, as long as patients have anatomies that do not preclude their use, but more data across the board regarding efficacy and safety is still needed, Drs. Vivek Reddy and Moussa Mansour discuss.

Read More
Tammy Griffin-Kumpey
A good year for big data

A good year for big data

Professor Camm noted various studies that have achieved great results in terms of characterizing best treatment options for certain patient groups, from antiarrhythmia drugs to ablation, surgery to electrophysiology.

Read More
Tammy Griffin-Kumpey